Form D · Pharmaceuticals

Little Pharma, Inc.

New York, NY · CIK 0001752787

Offering snapshot reported Sep 10, 2019 · SEC filing

Reported sold
$708K
Offering amount: $708K
Investors reported
21
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Aug 31, 2018
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$354K$708KSep 13, 2018: $557,500.00Sep 13, 2018Sep 10, 2019: $707,500.00Sep 10, 2019

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$557,500 → $707,500
  • Reported investors19 → 21

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 10, 2019Amendment$707,500$150,000vs Sep 13, 201821SEC filing
Sep 13, 2018Initial$557,500No comparison19SEC filing

Offering details

Securities
Security to be acquired, Other
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-321225
The Convertible Notes are outstanding but the underlying offering is complete.

Source: Form D, filed Sep 10, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Ethan Lauf Goldstein Director, Executive, Promoter

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
170 Amsterdam Avenue #6 C
New York, NY, 10023